comparemela.com

Ocular Therapeutix™ Announces 12-Month Topline Data from Ongoing U.S.-Based Phase 1 Clinical Trial Evaluating OTX-TKI for Treatment of Wet AMD

Ocular Therapeutix™ Announces 12-Month Topline Data from Ongoing U.S.-Based Phase 1 Clinical Trial Evaluating OTX-TKI for Treatment of Wet AMD
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

United States ,Utah ,Park City ,Antony Mattessich ,Arshadm Khanani ,Rabia Gurses Ozden ,Peterk Kaiser ,Mediaicr Westwickeben Shannon ,Icr Westwickechris Brinzey ,Clinical Research At Sierra Eye Associates ,Exchange Commission ,Nasdaq ,Ocular Therapeutix Inc ,Retinal Pharmaceuticals Market ,Clinical Research ,Sierra Eye Associates ,Clinical Trials ,Chief Executive Officer ,Month Topline Data ,Trial Evaluating ,Chief Medical Officer ,Ocular Therapeutix ,Chief Medical Advisor ,Retinal Pharmaceuticals Market Report ,Private Securities Litigation Reform Act ,Therapeutixdonald Notmanchief Financial Officer ,Chris Brinzey ,Ben Shannon ,

comparemela.com © 2020. All Rights Reserved.